Nephromegaly in children with Kawasaki disease: New supporting evidence for diagnosis and its possible mechanism

Pediatric Research

Volumn 63, Issue 2, 2008, Pages 207-210

  Huang, Hsin Ping ^b   Lai, Yi Chun ^a   Tsai, I Jung ^a   Chen, Shih Yu ^a   Cheng, Chi Hui ^c   Tsau, Yong Kwei ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FEVER; HUMAN; KIDNEY HYPERTROPHY; KIDNEY SIZE; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; SYMPTOMATOLOGY;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; INFANT; KIDNEY; KIDNEY DISEASES; MALE; MODELS, BIOLOGICAL; MUCOCUTANEOUS LYMPH NODE SYNDROME; ORGAN SIZE; RESEARCH DESIGN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 38349144352     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/PDR.0b013e31815ef737     Document Type: Article

References (24)

1. Kawasaki T 1967 [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi 16:178-222
2. Kawasaki T, Kosaki F, Osawa S, Shigemitsu I, Yanagawa S 1974 A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54:271-276
3. Morens DM, O'Brien RJ 1978 Kawasaki disease in the United States. J Infect Dis 137:91-93
4. Burns JC, Glode MP 2004 Kawasaki syndrome. Lancet 364:533-544
5. Desai A, Patel S, Book W 2005 'Myocardial infarction' in adolescents: do we have the correct diagnosis? Pediatr Cardiol 26:627-631
6. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association 2004 Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee of Rheumatic Fever, Endocarditis and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110:2747-2771
7. Melish ME, Hicks RM, Larson EJ 1976 Mucocutaneous lymph node syndrome in the Unites States. Am J Dis Child 130:599-607
8. Tsau YK, Lu MY, Ni YH 2001 Nephromegaly and elevated hepatocyte growth factor-transforming growth factor-β1 ratio in infants with fulminant hepatitis or biliary atresia. Am J Kidney Dis 38:279-285
9. Tsau YK, Jou ST, Ni YH 2002 Nephromegaly relates to hepatocyte growth factor dysregulation in biliary atresia. Pediatr Nephrol 17:554-559
10. Cheng CH, Tsau YK, Tsai IJ 2005 Kidney volume and plasma hepatocyte growth factor-transforming growth factor β1 ratio among children with biliary atresia before and after liver transplantation: the reversibility of nephromegaly. Am J Kidney Dis 46:830-836
11. Hricak H, Lieto RP 1983 Sonographic determination of renal volume. Radiology 148:311-312
12. Chu LW, Lu MY, Tsau YK 1999 Sonographic measurements of renal size in normal children and children with compensatory renal hypertrophy. Acta Paediatr Taiwan 40:18-21
13. Barrett TM, Broyer M, Chantler C, Gilli G, Guest G, Marti-Henneberg C, Preece MA, Rigden SP 1986 Assessment of growth. Am J Kidney Dis 7:340-346
14. Nardi PM, Haller JO, Friedman AP, Slovis TL, Schaffer RM 1985 Renal manifestations of Kawasaki disease. Pediatr Radiol 15:116-118
15. Veiga PA, Pieroni D, Batier W, Feld LG 1992 Association of Kawasaki disease and interstitial nephritis. Pediatr Nephrol 6:421-423
16. Lande MB, Gleeson JG, Sundel RP 1993 Kawasaki disease and acute renal failure. Pediatr Nephrol 7:593-594
17. Burns JC, Wiggins JW, Toews WH, Newburger JW, Leung DY, Wilson H, Glode MP 1986 Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 109:759-763
18. Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, Ishii M, Harada K. Kawasaki Disease Research Committee 2005 Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 47:232-234
19. Hsu YH, Wang YH, Hsu WY, Lee YP 1987 Kawasaki disease characterized by erythema and induration at the bacillus Calmette-Guerin and purified protein derivative inoculation sites. Pediatr Infect Dis J 6:576-578
20. Ohno T, Yuge T, Kariyazono H, Igarashi H, Joh-o K, Kinugawa N, Kusuhara K, Hara T 2002 Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr 161:105-111
21. Tsau YK, Tsai IJ, Chen YM 2006 Transient reciprocal change of renal hepatocyte growth factor and transforming growth factor-β1 may relate to renal hypertrophy in rats with liver injury or unilateral nephrectomy. Pediatr Res 59:494-499
22. Nagaike M, Hirao S, Tajima H, Noji S, Taniguchi S, Matsumoto K, Nakamura T 1991 Renotropic functions of hepatocyte growth factor in renal regeneration after unilateral nephrectomy. J Biol Chem 266:22781-22784
23. Taipale J, Keski-Oja J 1996 Hepatocyte growth factor releases epithelial and endothelial cells from growth arrest induced by transforming growth factor-β1. J Biol Chem 271:4342-4348
24. Matsumoto K, Mizuno S, Nakamura T 2000 Hepatocyte growth factor in renal regeneration, renal disease and potential therapeutics. Curr Opin Nephrol Hypertens 9:395-402